Bridging the Transparency Gap: Trump Administration Overhauls Health Insurance Disclosure Rules on October 6, 2026 Posted by
Legal Showdown: Federal Appeals Court Skeptical of HHS in High-Stakes Medicare Advantage Audit Battle on October 6, 2026 Posted by
GE HealthCare Bolsters Radiopharmaceutical Dominance with Strategic Acquisition of Sofie Biosciences on October 6, 2026 Posted by
Unpacking the Disparities: How Maternal Health and Ethnicity Intersect in Autism Risk on October 6, 2026 Posted by
Shionogi Scales Up Rare Disease Ambitions with $2 Billion IntraBio Acquisition on October 5, 2026 Posted by
Celebrating Excellence: Honoring the Vital Contributions of Respiratory Therapists in Our Communities on October 5, 2026 Posted by
Bridging the Transparency Gap: Trump Administration Overhauls Health Insurance Disclosure Rules on October 6, 2026 Posted by
Legal Showdown: Federal Appeals Court Skeptical of HHS in High-Stakes Medicare Advantage Audit Battle on October 6, 2026 Posted by
GE HealthCare Bolsters Radiopharmaceutical Dominance with Strategic Acquisition of Sofie Biosciences on October 6, 2026 Posted by
Unpacking the Disparities: How Maternal Health and Ethnicity Intersect in Autism Risk on October 6, 2026 Posted by
Posted in Medical Innovations Lung Cancer Breakthroughs: How New Data from WCLC Is Reshaping Oncology on September 15, 2026
Posted in Medical Innovations The Persistent Crisis: NCCN Report Highlights Chronic Shortages of Life-Saving Cancer Medications on September 15, 2026
Posted in Medical Innovations Health Policy and Science Update: From Space Medicine to Shifts in Public Trust on September 15, 2026
Posted in Medical Innovations A New Frontier in SMA Treatment: FDA Clears Scholar Rock’s Isembyld on September 15, 2026
Posted in Medical Innovations New Frontier in Lung Cancer: Zidesamtinib Shows Unprecedented Efficacy in Frontline ROS1-Positive NSCLC Treatment on September 15, 2026
Posted in Medical Innovations Biotech Briefing: AstraZeneca’s Clinical Setback and a Milestone for Spinal Muscular Atrophy on September 15, 2026
Posted in Medical Innovations Pivot to the Heart: Cellectis Abandons Allogeneic Cell Therapy Ambitions to Pursue Cardiovascular Gene Editing on September 15, 2026
Posted in Medical Innovations Abbott Laboratories Reaches $385 Million Settlement Over Sturgis Contamination Crisis on September 15, 2026
Posted in Medical Innovations Public Health Crisis: Pennsylvania Records Third Measles-Related Death as Discrepancies Emerge in National Reporting on September 15, 2026
Posted in Medical Innovations AstraZeneca’s Etcamah Hits Clinical Roadblock: What the SERENA-4 Failure Means for the Future of Oral SERDs on September 15, 2026
